Literature DB >> 2328266

Purification and characterization of a new arginine carboxypeptidase in human serum.

D Hendriks1, W Wang, S Scharpé, M P Lommaert, M van Sande.   

Abstract

A carboxypeptidase capable of cleaving basic amino acids from synthetic peptide substrates is present in fresh human serum, and not in human heparinized plasma. Its activity is generated during the process of coagulation. Because of its unstability at room temperature and at 37 degrees C, we named it unstable carboxypeptidase (carboxypeptidase U). Carboxypeptidase U was partially purified from fresh human serum by chromatography on DEAE-cellulose and Mono-Q sepharose and was found to be a 435 kDa protein. We compared this enzyme with carboxypeptidase N, purified from human serum by a two-step affinity chromatography on arginine-Sepharose 4B, followed by ion-exchange chromatography on Mono-Q sepharose. Carboxypeptidase U cleaves hippuryl-L-arginine and hippuryl-L-lysine, but at a different relative rate than carboxypeptidase N, and has no esterase activity on hippuryl-L-argininic acid. Its activity was inhibited by o-phenanthroline, DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid, CoCl2, 2-mercaptoethanol, dithiothreitol and 4-chloromercuribenzoic acid. These characteristics differentiate carboxypeptidase U from carboxypeptidase N and other known carboxypeptidases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328266     DOI: 10.1016/0304-4165(90)90157-r

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.

Authors:  Jonathan H Foley; Paula Kim; Michael E Nesheim
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

2.  Novel bifunctional hyperthermostable carboxypeptidase/aminoacylase from Pyrococcus horikoshii OT3.

Authors:  K Ishikawa; H Ishida; I Matsui; Y Kawarabayasi; H Kikuchi
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

3.  Immobilized carboxypeptidase N. A potent bioreactor and specific adsorbent for peptides.

Authors:  W Wang; D F Hendriks; S L Scharpé
Journal:  Appl Biochem Biotechnol       Date:  1994-02       Impact factor: 2.926

4.  Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

Authors:  P A Von dem Borne; L Bajzar; J C Meijers; M E Nesheim; B N Bouma
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Flexibility of the thrombin-activatable fibrinolysis inhibitor pro-domain enables productive binding of protein substrates.

Authors:  Zuzana Valnickova; Laura Sanglas; Joan L Arolas; Steen V Petersen; Christine Schar; Daniel Otzen; Francesc X Aviles; F Xavier Gomis-Rüth; Jan J Enghild
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

6.  Endogenous human milk peptide release is greater after preterm birth than term birth.

Authors:  David C Dallas; Christina J Smink; Randall C Robinson; Tian Tian; Andres Guerrero; Evan A Parker; Jennifer T Smilowitz; Kasper A Hettinga; Mark A Underwood; Carlito B Lebrilla; J Bruce German; Daniela Barile
Journal:  J Nutr       Date:  2014-12-24       Impact factor: 4.798

7.  The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa.

Authors:  Kanchan Anand; Irantzu Pallares; Zuzana Valnickova; Trine Christensen; Josep Vendrell; K Ulrich Wendt; Herman A Schreuder; Jan J Enghild; Francesc X Avilés
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

8.  The peptidase activity of human serum butyrylcholinesterase: studies using monoclonal antibodies and characterization of the peptidase.

Authors:  R V Rao; A S Balasubramanian
Journal:  J Protein Chem       Date:  1993-02

9.  Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI).

Authors:  Zuzana Valnickova; Morten Thaysen-Andersen; Peter Højrup; Trine Christensen; Kristian W Sanggaard; Torsten Kristensen; Jan J Enghild
Journal:  BMC Biochem       Date:  2009-05-05       Impact factor: 4.059

10.  Inactivation of the complement anaphylatoxin C5a by secreted products of parasitic nematodes.

Authors:  Dominic Rees-Roberts; Lisa M Mullen; Kleoniki Gounaris; Murray E Selkirk
Journal:  Int J Parasitol       Date:  2009-10-27       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.